Raziel Green, 52, an active runner and mother of two, was diagnosed with a rare form of ALS in 2017. Since starting a ...

CNM-Au8 prolonged survival for people with ALS relative to those who received the investigational treatment zilucoplan or a ...

A Regina mother who was one of the first ALS patients to test a new treatment is now celebrating its accelerated approval in ...

Researchers have revealed a new scientific clue that could unlock the key cellular pathway leading to devastating neurodegenerative diseases like Alzheimer's disease and amyotrophic lateral sclerosis ...

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Four investigational ALS treatments failed in phase II studies, but CNM-Au8 and pridopidine showed promising trends.

Sebastien Beauzile lived with the chronic pain of sickle cell anemia. Now, thanks to a groundbreaking genetic treatment, he ...

Among participants who met the core RESTORE-ALS Trial criteria (e.g., baseline serum NfL > 33 pg/mL, TRICALS risk score range between –6.5 and –2.5, baseline slow vital capacity > 60%, and symptom ...

AKGsOVIHAMS, a leading healthcare institution, has marked progress in treating ALS using integrative medicine. Known for combining conventional and alternative therapies, the institute has shown ...

Pathmaker's MyoRegulator is designed to ease hyperexcitability and delivers an electrical current to the spinal cord and ...

Sarasota-Manatee partnership offers free hearing support; job fairs in Bradenton, Sarasota; Goodwill opens LWR outlet; arts ...

Patients increasingly complain that it is difficult to win approval from health insurance companies for certain types of treatment. Now, the ALS Association has introduced a new tool, the ALS ...

Clene (CLNN) and its subsidiary, Clene Nanomedicine announced new evidence from a cross-regimen, post hoc analysis of long-term survival in ...